Area of research
Molecular Biology · Immunology
Research interest
Research interests include Medicine, Radiation therapy, Oncology, Glioblastoma, STK11, and Internal medicine.
A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma
<i>STK11</i> /LKB1 Mutations in NSCLC Are Associated with KEAP1/NRF2-Dependent Radiotherapy Resistance Targetable by Glutaminase Inhibition
Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa
A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma